These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3770373)

  • 1. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.
    Brignola C; Campieri M; Bazzocchi G; Farruggia P; Tragnone A; Lanfranchi GA
    Gastroenterology; 1986 Dec; 91(6):1490-4. PubMed ID: 3770373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal permeability test as a predictor of clinical course in Crohn's disease.
    D'Incà R; Di Leo V; Corrao G; Martines D; D'Odorico A; Mestriner C; Venturi C; Longo G; Sturniolo GC
    Am J Gastroenterol; 1999 Oct; 94(10):2956-60. PubMed ID: 10520851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study.
    Brignola C; Campieri M; Farruggia P; Tragnone A; Pasquali S; Iannone P; Lanfranchi GA; Barbara L
    J Clin Gastroenterol; 1988 Dec; 10(6):631-4. PubMed ID: 3230278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum.
    Biancone L; Fantini M; Tosti C; Bozzi R; Vavassori P; Pallone F
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):261-6. PubMed ID: 12610321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study.
    Ludwig D; Wiener S; Brüning A; Schwarting K; Jantschek G; Stange EF
    Am J Gastroenterol; 1999 Oct; 94(10):2942-50. PubMed ID: 10520849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of laboratory parameters in the evaluation of Crohn's disease activity.
    Brignola C; Lanfranchi GA; Campieri M; Bazzocchi G; Devoto M; Boni P; Farruggia P; Veggetti S; Tragnone A
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 1):245-8. PubMed ID: 3734355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.
    Louis E; Belaiche J; van Kemseke C; Franchimont D; de Groote D; Gueenen V; Mary JY
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):939-44. PubMed ID: 9391781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
    Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease.
    André C; Descos L; Vignal J; Gillon J
    Scott Med J; 1983 Jan; 28(1):26-9. PubMed ID: 6403982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
    Andre C; Descos L; Landais P; Fermanian J
    Gut; 1981 Jul; 22(7):571-4. PubMed ID: 6973509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.
    Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K
    World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
    Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.